Skip to main content

Table 1 Focus Group participant demographics, breast cancer risk, N = 32

From: Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: a focus group study

Characteristic  
Mean Age 48 (25–67)
Education
 Some High School 2 (6 %)
 Some College 5 (16 %)
 College Degree 11 (34 %)
 Graduate Degree 14 (44 %)
Ancestry  
 European 16 (50 %)
 African 10 (31 %)
 Other 6 (19 %)
Ethnicity
 Hispanic 4 (13 %)
 Non-Hispanic 28 (87 %)
Mean Age of Menarche 12 (9–17)
Mean Age at 1st Live Birth 29 (16–39)
1st or 2nd Degree Female Relative with Breast Cancer 21 (66 %)
History of Breast Biopsy 16 (50 %)
History of Biopsy with Atypia 3 (9 %)
BRCA 1/2 Mutation Carrier 0 (0 %)
BIRADS Mammographic Density
 0 – No Mammogram 3 (9 %)
 1 – Fatty 1 (3 %)
 2 – Scattered Fibroglandular 9 (28 %)
 3 – Heterogeneously Dense 19 (60 %)
 4 – Extremely Dense 0 (0 %)
Prior Knowledge of Preventive Medicines 6 (19 %)
MD Recommended Preventive Medicine 2 (6 %)
Estimated Breast Cancer Risk (Gail Model)
 Above Peer Average 23 (72 %)
 At Peer Average 3 (9 %)
 Below Peer Average 6 (19 %)